Proactive Investors - Run By Investors For Investors

Scancell Holdings PLC’s technology underpinned by latest deal, says joint chief

Immunotherapy group Scancell Holdings PLC (LON:SCLP) is teaming up with Sweden’s leading research organisation Karolinska Institutet – run by the 2011 chair of the Nobel Assembley at Karolinska - Lars Klareskog.

The firm said it hopes will aid the development of one of its two breakthrough technologies and Richard Goodfellow, joint chief executive, speaks to Proactive about the collaboration.

He says the tie-up “really underpins the quality of the technology at Scancell”, adding that the experience and knowledge of Klareskog and his team will “strengthen” its science.

Meet Gold Road Resources Ltd, Cellmid Ltd, Gold Road Resources Ltd, Altech Chemicals Ltd and Silver City Minerals Ltd at our event, Sydney, 03 October 2017. Register here »
Why Invest In Scancell Holdings Plc? Read More Here

Register here to be notified of future Scancell Holdings Plc articles
View full SCLP profile View Profile

Scancell Holdings Plc Timeline

January 31 2017

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use